A carregar...
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study
OBJECTIVE: To examine long-term efficacy/safety of ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, added to ongoing insulin therapy in Japanese patients with type 2 diabetes. METHODS: We conducted a 36-week, open-label extension of ipragliflozin therapy following a 16-week, randomized, pl...
Na minha lista:
| Publicado no: | Diabetol Int |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Japan
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357239/ https://ncbi.nlm.nih.gov/pubmed/30800562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-018-0359-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|